ArticleThe veterinary quarterly2025

Evaluation of the safety and immunogenicity of a peptide vaccine against canine leishmaniosis: a double-blind, multicenter, controlled clinical trial in dogs.

Clara Hurtado-Morillas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.